928842-48-2

Upstream product

• 928842-47-1 (R)-8-(tert-butyldiphenylsilyloxy)-6-(methoxymethoxy)octanoic acid 
• 372504-89-7 (R)-4-benzyl-2-oxazolidinone lithium salt 
• 728943-78-0 (R)-methyl 8-tert-butyldiphenylsilyloxy-6-metoxymethoxyoctanoate 

Downstream Products

• 928842-49-3 (R)-4-benzyl-3-[(2R,6R)-8-(tert-butyldiphenylsilyloxy)-2-hydroxy-6-(methoxymethoxy)octanoyl]-2-oxazolidinone 
• 928842-54-0 (2S,6S)-2-(2-(tert-butyldiphenylsilyloxy)ethyl)-6-methyltetrahydropyran 
• 928842-53-9 (2S,6R)-8-(tert-butyldiphenylsilyloxy)-6-hydroxyoct-2-yl acetate 
• 928842-52-8 (2S,6R)-8-(tert-butyldiphenylsilyloxy)-6-(methoxymethoxy)-oct-2-yl acetate 
• 928842-51-7 (2S,6R)-8-(tert-butyldiphenylsilyloxy)-6-(methoxymethoxy)-2-octanol 
• 928842-50-6 (2R,6R)-8-(tert-butyldiphenylsilyloxy)-6-(methoxymethoxy)-1,2-octanediol 

Relevant academic research and scientific papers

Synthesis of a glandular secretion of the civet cat, (2S,6S)-(6- methyltetrahydropyran-2-yl)acetic acid and its enantiomer, by using the yeast-reduction product and recovered substrate from yeast reduction

A glandular secretion of the civet cat, (2S,6S)-(6-methyltetrahydropyran-2- yl)acetic acid 1 and its enantiomer, were synthesized from the yeast-reduction product and recovered substrate from yeast reduction.